Posts Tagged ‘winship cancer institute’

Why I Run: To Raise Awareness & Funding For My Dad’s Cancer

Nething Family Melanoma Patient StoryWhen Sarah Nething learned that her father’s melanoma had come back, she knew it was time to take charge in the fight against cancer. “When cancer comes, you feel kind of helpless,” says Sarah. “Our family believes very strongly in the power of prayer, but you still feel like you want to do something.” And Sarah is doing something. As the oldest of ten children and a graduate student in South Carolina, Sarah has set up a team for the Winship Cancer Institute of Emory University’s Win the Fight 5K Run/Walk.

“I can’t take away my dad’s cancer; however, I can participate in something that raises research money to help the doctors try to figure out how to stop it,” says Sarah. So on October 5, Sarah and other members of the Nething family will run the 5K in their father’s honor. Their team – Race for Matt – is running to not only raise general awareness, but also funds for Winship’s Melanoma & Skin Cancer Fund. The Winship Melanoma & Skin Cancer Fund is one of 18 funds which Winship 5K participants can direct their donations to.

In preparing for the upcoming race, Sarah has yet to lose any motivation. “A friend of ours describes how our family feels perfectly when he says ‘Trust God completely, fight cancer aggressively.’ That’s exactly what we plan to do,” she concludes.

If you are interested in learning more about the Win the Fight 5K, want to run or simply help support other runners like the Nething family, visit the Winship 5K website for more information.

Related Resources:

Support Changes & Saves Lives for Bone Marrow Transplant Patients

William Fuentes, a father of two pre-schoolers and a manager at a McDonald’s, had a very busy life in Calhoun, Georgia, one of Atlanta’s northern suburbs. While his wife took care of the little ones, he still tried to help out around the house while managing the duties of a busy restaurant.

William’s busy life only got more complicated when the 30-year-old was diagnosed in 2012 with multiple myeloma, a disease he had never even heard of. The intense back pain he felt turned out to be a result of the disease. He was rushed to the hospital in an ambulance, and then he had to have surgery to repair some of the damage in his back.

And then treatment started. He needed a bone marrow transplant, often a complicated procedure best handled by a team that has a breadth and depth of experience to handle complications that may arise. He turned to the Emory Bone Marrow & Stem Cell Transplant Center of the Winship Cancer Institute of Emory University.

William Fuentes Multiple Myeloma Bone Marrow Transplant Patient

William Fuentes with his family.

William recalls being so afraid and yet wanting to be strong for his children. After they would go to sleep at night, sometimes he cried, he said.

“I just felt so all alone,” William recalls.

But he found the support he received from Winship and the Bone Marrow & Stem Cell Transplant Center not only saved his life, but changed his life. Enrollment in a clinical trial gave him access to a drug that worked on his type of myeloma, something he may not have received had he been treated elsewhere. Equally important to him was the compassionate care he received from his physician, Dr. Ajay Nooka, and the bone marrow transplant team.

“He is the nicest man I’ve ever met,” William said. “I couldn’t have asked for better treatment,” he says. Winship social workers made sure gas cards were available when funds ran low. A team of employees from the clinical trials unit came together and provided Christmas gifts for the Fuentes family.

“My wife is so thankful. We love it here,” says William.

Related Resources:

Cancer Researchers, Patients Support Winship 5K Side-by-Side

Winship 5K on FacebookOne of the most inspiring parts of Winship Cancer Institute of Emory University’s Win the Fight 5K race is seeing physicians and researchers run alongside their patients. In fact, many members of the Winship care team turn out on race day to support the cause, and many even host their own teams. Among these participants is Donald Harvey, PharmD, and director of Winship’s Phase I Clinical Trials Unit.

Dr. Harvey and other researchers in the Phase I unit work with volunteer participants to test the safety of new drugs and treatments and identify possible side effects. Winship’s Phase I Center is one of only two such units in Georgia and by far the largest and busiest, with 38 trials conducted in 2011 and research that has led to four drugs in the FDA approval pipeline. These drugs will hopefully go on to cure people of cancer or extend their lives for many years.

Valerie Harper: An Energetic Will to Fight in the Face of Cancer

Valerie Harper Cancer DiagnosisWhat would you do if you were told you had an incurable disease and possibly only months to live? Actress Valerie Harper recently had to ask herself that question. This past January, Harper, best known for her role as Rhoda Morgenstern in The Mary Tyler Moore Show, was told she has leptomeningeal carcinomatosis, a rare form of incurable brain cancer.

Doctors told Harper, who already has battled lung cancer, that she could have as little as three months to live. Since going public with her news back in March, Harper has mentioned in several media appearances that she has gained strength from opening up about her battle with cancer. In an interview with CNN’s Piers Morgan, Harper displayed great courage and an even greater attitude when asked about her devastating diagnosis. “There’s other ways to handle it than just sit on the couch and accept.”  Through her actions, Harper has demonstrated that she is doing anything but ‘sit on the couch and accept.’

Now, eight months since her diagnosis, Harper has yet to slow down. Instead, she is doing book tours and TV appearances, exercising and even starring in an upcoming TV movie, set to air January 2014.

The Merriam-Webster Dictionary definition of willpower is “energetic determination,” while the Cambridge American English Dictionary defines it as “the ability to control your own thoughts and behavior, especially in difficult situations.”

A cancer diagnosis affects each patient and his or her family members differently. Some people may enter a state of severe depression, while others go about their normal activities while only stopping to receive treatment. For Harper, energetic determination is the key to making sure every day is the best it can be.

What are your thoughts on Valerie’s reaction to her earth-shattering diagnosis? Do you think her willpower has anything to do with her outlook on life, or could it be her coping mechanism?

At Winship Cancer Institute of Emory University, we understand that life after a cancer diagnosis can be anything but ordinary. Because of this understanding, we have developed our survivorship program to meet the needs of cancer survivors at any stage of cancer, from diagnosis to post-treatment. For more information on the Winship Survivorship Program, email survivorship@emoryhealthcare.org or call 404-778-0572.

Related Resources:

Winship Cancer Institute Recognized Among Best Cancer Centers in the U.S. by Men’s Health Magazine!

Best Cancer Hospitals in the U.S.Winship Cancer Institute of Emory University has been named among the best cancer centers in the United States according to Men’s Health magazine!

The publication recognized Winship for its multi-specialty patient care and advanced clinical research. As Georgia’s first and only NCI-designated cancer center, Winship is honored to be the only hospital in Atlanta ranked on the best cancer centers list, and also recognized as one of the nation’s top cancer facilities.

From discovering a new treatment method for prostate cancer, to providing cancer survivors with unique support and wellness programs, at Winship, we are constantly working to discover better ways to prevent, detect, and treat many types of cancer.

Thank you to our community for inspiring us to bridge innovative medical research and technology with compassionate patient and family-centered care, each and every day. We are honored by this recognition!

Related Resources:

New Treatment for Prostate Cancer: Saint Joseph’s Hospital First in State to Treat Patient with Xofigo

Xofigo new prostate cancer treatment medicationA double bass player in the Atlanta Symphony Orchestra, Doug Sommer claims he was just “in the right place at the right time with the right doctors,” when he was offered the opportunity to be the first in the state to receive a new treatment option for his prostate cancer.

Doug is the first patient in Georgia to receive a new FDA-approved radioactive therapeutic drug for advanced metastatic prostate cancer. He received the treatment, a single injection of radium Ra 223 dichloride, (brand name Xofigo) at Saint Joseph’s Hospital. This was the first of six injections. Xofigo has been shown to reduce bone pain and improve quality of life.

“Patients with a type of cancer called castration-resistant prostate cancer (CRPC) with metastatic bone disease, who have failed hormone suppression therapy, now have a new treatment option for their disease.”

- Peter Rossi, MD, medical director of radiation oncology at Saint Joseph’s Hospital and assistant professor of radiation oncology at Emory University School of Medicine & Winship Cancer Institute

Read more about this new treatment for prostate cancer on the Saint Joseph’s Hospital blog >>

Survivor Story: Debbie Church’s Battle with Breast Cancer

Debbie Church

Debbie Church is Coordinator of the Cancer Survivors’ Network and Patient Navigator at Saint Joseph’s Hospital and a 5-year breast cancer survivor. Debbie has shared her story through the journey of survivorship below. We’re lucky to have Debbie and Saint Joseph’s Hospital as part of the Emory Healthcare family and we thank her for sharing her story. We hope our readers and community members are as inspired by her story as we are!

“Dick and I fell in love over 32 years ago and have never quite gotten over it! We have had some interesting moments, but we have made it through each challenge. Love always finds a way. Unexpectedly, our lives changed in an instant when I was diagnosed with breast cancer in December of 2008. We knew life would never be the same. Life is like that box of chocolates – you never know what you’re going to get.”

Read more of Debbie’s story on the Saint Joseph’s Hospital blog >>

About Debbie Church, BA
Debbie Church, BA in Psychology and History, Salem College, and a M.Div. from Southeastern Seminary Wake Forest and a Certified Cancer Services Navigator has worked in oncology for over 20 years. She is currently employed at St. Joseph’s Hospital of Atlanta as Coordinator of the Cancer Survivors’ Network and Patient Navigator. She has worked also as Director of Support Services and Chaplain at Northwest Georgia Oncology Centers, Atlanta Medical Center and various hospitals in the Southeast. She has spoken at many cancer events including GASCO Conferences here in Atlanta and other hospice and oncology centers in the southeast. She was a contributing author for Thomas Nelson’s Women’s Study Bible as well as publishing a book in 2010 with her husband, Don’t’ Ever Look Down; Surviving Cancer Together.

Winship Cancer Institute, Emory Break Ground on $200+ Million Emory Proton Therapy Center!

A new era in cancer treatment in Georgia recently began as Emory Healthcare and Winship Cancer Institute broke ground on the first facility in Georgia to offer the most advanced radiation therapy possible – proton beam therapy.

Proton therapy is the next generation of radiation oncology. It uses protons to precisely treat cancerous tumors and minimize radiation to the healthy tissue surrounding the tumor. For certain cancers, and for pediatric cancer patients, it may provide more effective treatment with fewer side effects. This innovative therapy is offered at fewer than a dozen centers in the United States but is available in other countries and more than 110,000 people worldwide have received this FDA-approved therapy.  The Emory facility is being built in partnership with Advanced Particle Therapy, LLC of San Diego, CA.

Proton therapy may be most beneficial for patients with cancerous our benign tumors in certain anatomic areas, including  the brain, prostate, liver, esophagus, head and neck and the base-of-skull.  It’s also  beneficial for treating children because of the risk to growth and developmental from conventional radiation.  Studies in children have shown that proton therapy minimizes damage to healthy tissues and produces fewer side effects.

The Emory Proton Therapy Center will enable Winship researchers  to continue studying the benefits of proton therapy, with the goal of producing better outcomes for our patients.  At Winship we constantly seek out the most effective treatment available, and for many of our patients, proton therapy is that treatment.

As Georgia’s only National Cancer Institute designated cancer center, Winship is committed to cancer research projects which improve our patients’ lives.

About Dr. Curran

Walter J. Curran, Jr. was appointed Executive Director of the Winship Cancer Institute of Emory University in September 2009. He joined Emory in January 2008, as the Lawrence W. Davis Professor and Chair of Radiation Oncology and Chief Medical Officer of the Winship Cancer Institute.

Dr. Curran, who is a Georgia Cancer Coalition Distinguished Cancer Scholar, has been a principal investigator on several National Cancer Institute (NCI) grants and is considered an international expert in the management of patients with locally advanced lung cancer and malignant brain tumors. He has led several landmark clinical and translational trials in both areas and is responsible for defining a universally adopted staging system for patients with malignant glioma. He serves as the Founding Secretary/Treasurer of the Coalition of Cancer Cooperative Groups and a Board Member of the Georgia Center for Oncology Research and Education (Ga CORE). Dr. Curran is the only individual currently serving as director of an NCI-designated cancer center and as group chairman of an NCI-supported cancer cooperative group, the Radiation Therapy Oncology Group.

Dr. Curran is a Fellow in the American College of Radiology and has been awarded honorary memberships in the European Society of Therapeutic Radiology and Oncology and the Canadian Association of Radiation Oncology. In 2006, he was named the leading radiation oncologist/cancer researcher in a peer survey by the journal Medical Imaging. Under Dr. Curran’s leadership Emory’s Radiation Oncology Department has been recently selected as a “Top Five Radiation Therapy Centers to Watch in 2009” by Imaging Technology News. Dr. Curran ranked among the top 10 principal investigators in terms of overall NCI funding in 2010 and among the top 20 principal investigators in overall NIH funding in 2010.

Related  Resources

Cancer Survival Rates Expected to Rise by 37% over 10 years!

By the year 2022, there will be 18 million cancer survivors living in the United States, according to a recent report by the American Association for Cancer Research. The report points out that as survival rates increase and cancer survivors become an ever-growing portion of the population, a coordinated effort will become crucial to meeting long-term medical, psychosocial and practical needs.

When news of the boost in survivor numbers made headlines, CNN Newsroom anchor Brooke Baldwin brought Emory surgical oncologist Charles Staley, MD on set to interview him as both a cancer doctor, and a cancer survivor. Watch the full interview below:

As more people are living longer after a cancer diagnosis it is very important to educate survivors on the after effects, long term effects, nutrition, and fitness following cancer care. Winship Cancer Institute at Emory University has a Survivorship program to help patients get back to life after surviving cancer. Get more information about the survivorship program.

Over the course of the next few months we will highlight many different areas of survivorship on the Winship blog so make sure to follow us to get more detailed information on living after cancer.

Dr. Charles StaleyAbout Dr. Charles Staley

Dr. Staley is the Chief of Surgical Oncology for Emory University Hospital and Chief Medical Officer for Winship Cancer Institute of Emory University. Dr. Staley specializes in treating cancers of the esophagus, pancreas, stomach, liver, small bowel and rectum. He has investigated gene therapy for metastatic colon cancer and radiofrequency ablation with intra-arterial chemotherapy for patients with colorectal liver metastases. Currently, he and his colleagues are exploring methods of using nanotechnology to treat and diagnose pancreatic and breast cancer. He joined Emory University School of Medicine faculty in 1995 after a surgical fellowship at MD Anderson Cancer Center in Houston. Dr. Staley earned his medical degree at Dartmouth University School of Medicine and conducted his residency at the University of Pittsburgh’s University Health Center. Dr. Staley is an active member of the American Society of Clinical Oncology, The Georgia Surgical Society, and the Society of Surgical Oncology.

Related Resources:

The Skinny on Neuroendocrine Cancer

Neuroendocrine tumors develop in the cells of the neuroendocrine system, a network of glands throughout the body that produce hormones. Neuroendocrine tumors are rare, typically affecting 1 – 2 people per 100,000 people.

The different types of neuroendocrine tumors depend on the particular cells that are affected.  They usually develop in the digestive system and the lungs.  Approximately 38% of tumors are in the appendix, 23% in the ileum (also known as carcinoids), 13% in the rectum and 11.5% in the bronchi.

Symptoms of Neuroendocrine tumors

Neuroendocrine tumors may be slow growing (low grade or well differentiated) or rapidly growing (high grade or poorly differentiated).  They may be functional (release hormones) or nonfunctional.  When functional neuroendocrine tumors release a variety of hormones including a hormone called serotonin, a condition called carcinoid syndrome may occur. Symptoms most commonly associated with neuroendocrine tumors include flushing, diarrhea, weight loss, abdominal pain and cramping.   Patients with carcinoid syndrome may also experience cardiac changes, which are caused from fibrotic damage to the heart.  Usually a patient with carcinoid syndrome does not experience these symptoms until the tumor has spread within the body.

Other terms used for neuroendocrine tumors include
• Gastroenteropancreatic neuroendocrine tumors – tumors in the gut or pancreas
• Pancreatic neuroendocrine tumors – also known as islet cell cancer, or PNET
• Gastrointestinal neuroendocrine tumors – tumors that develop in the bowel, stomach or esophagus
• Pheochromocytoma of the adrenal gland
• Carcinoid tumors of the lung or intestinal tract
• Carcinoid Syndrome
• Gastrinoma, Insulinoma, Glucagonoma, VIPoma (vasoactive intestinal peptide tumor)

Treatment of neuroendocrine tumors

Treating neuroendocrine tumors can be a challenge due to the various types, locations in the body, the symptoms they produce and the diverse number of treatment modalities. Treatment is individualized to  each patient but can include surgery, liver directed therapy, medications, and/or radiation.

When treating a rare, challenging cancer such as neuroendocrine cancer, it is important to have a team of healthcare professionals at your side who are experts in the  disease and can collaborate to create a treatment plan individualized to each patient.

At Winship Cancer Institute of Emory University, we take this multidisciplinary approach with teams of  expert medical oncologists, surgical oncologists, interventional oncologists, gastroenterologists, pulmonologists, endocrinologists, nurses, and dieticians ( just to name a few) to create a care plan unique to each patient.

About Bonnie Josaphs, RN, BSN, OCN

Ms. Josaphs received her Bachelor of Science in Nursing from the University of Delaware, Newark, Delaware in 2002. She has been practicing within Gastrointestinal (GI) Oncology since 2004.  She specializes in gastrointestinal cancers which include cancers of the esophagus, liver, colon, rectum, pancreas, gallbladder and stomach.

Related Links

More information on neuroendocrine tumors:
Winship Cancer Institute Clinical Trials for Neuroendocrine Tumors
 The Winship Cancer Institute of Emory University is Georgia’s only NCI-designated Cancer Center.